Meiji Yasuda Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
153,980
+25,754
+20% +$2.08M 0.54% 42
2026
Q1
$11.1M Sell
128,226
-737
-0.6% -$70.6K 0.55% 35
2025
Q4
$12.4M Sell
128,963
-1,361
-1% -$132K 0.6% 29
2025
Q3
$12.4M Sell
130,324
-2,459
-2% -$226K 0.59% 30
2025
Q2
$11.6M Sell
132,783
-12,114
-8% -$1.03M 0.57% 34
2025
Q1
$13M Sell
144,897
-25,757
-15% -$2.3M 0.52% 36
2024
Q4
$13.6M Sell
170,654
-1,031
-0.6% -$89.3K 0.52% 38
2024
Q3
$15.5M Buy
171,685
+967
+0.6% +$81.3K 0.59% 32
2024
Q2
$13.4M Buy
170,718
+18,754
+12% +$1.54M 0.55% 35
2024
Q1
$13.2M Sell
151,964
-29,141
-16% -$2.49M 0.56% 38
2023
Q4
$14.9M Buy
181,105
+5,645
+3% +$430K 0.67% 26
2023
Q3
$13.7M Buy
175,460
+5,220
+3% +$437K 0.64% 26
2023
Q2
$15M Sell
170,240
-6,589
-4% -$567K 0.75% 24
2023
Q1
$14.3M Buy
176,829
+31,543
+22% +$2.57M 0.74% 24
2022
Q4
$11.3K Buy
145,286
+31,030
+27% +$2.51M 0.54% 42
2022
Q3
$9.23M Buy
114,256
+34,273
+43% +$3.08M 0.54% 35
2022
Q2
$7.18M Sell
79,983
-5,782
-7% -$586K 0.42% 53
2022
Q1
$9.52M Buy
85,765
+32,365
+61% +$3.42M 0.52% 43
2021
Q4
$5.52M Sell
53,400
-13,932
-21% -$1.61M 0.34% 71
2021
Q3
$8.44M Sell
67,332
-75
-0.1% -$9.71K 0.6% 36
2021
Q2
$8.37M Sell
67,407
-3,084
-4% -$387K 0.4% 58
2021
Q1
$8.33M Buy
70,491
+24,035
+52% +$2.82M 0.62% 38
2020
Q4
$5.44M Buy
46,456
+1,155
+3% +$127K 0.54% 50
2020
Q3
$4.71M Sell
45,301
-9,620
-18% -$966K 0.52% 46
2020
Q2
$5.04M Buy
54,921
+32,713
+147% +$3.14M 0.48% 51
2020
Q1
$2M Sell
22,208
-42,134
-65% -$4.48M 0.38% 66
2019
Q4
$7.3M Sell
64,342
-348
-0.5% -$38.2K 0.61% 39
2019
Q3
$7.03M Buy
64,690
+3,103
+5% +$324K 0.57% 44
2019
Q2
$6M Sell
61,587
-945
-2% -$86.3K 0.5% 49
2019
Q1
$5.7M Buy
62,532
+3,610
+6% +$323K 0.48% 60
2018
Q4
$5.36M Buy
58,922
+5,627
+11% +$526K 0.5% 52
2018
Q3
$5.24M Buy
53,295
+1,100
+2% +$102K 0.43% 64
2018
Q2
$4.47M Buy
52,195
+690
+1% +$57.6K 0.4% 70
2018
Q1
$4.13M Buy
51,505
+2,120
+4% +$175K 0.39% 72
2017
Q4
$3.99M Sell
49,385
-210
-0.4% -$16.8K 0.38% 73
2017
Q3
$3.86M Sell
49,595
-3,780
-7% -$314K 0.38% 76
2017
Q2
$4.74M Sell
53,375
-840
-2% -$70.8K 0.48% 56
2017
Q1
$4.37M Sell
54,215
-5,830
-10% -$455K 0.47% 58
2016
Q4
$4.28M Buy
60,045
+7,670
+15% +$603K 0.48% 56
2016
Q3
$4.53M Buy
52,375
+11,700
+29% +$1.02M 0.53% 50
2016
Q2
$3.53M Buy
40,675
+22,095
+119% +$1.79M 0.51% 58
2016
Q1
$1.39M Buy
18,580
+485
+3% +$36.5K 0.32% 80
2015
Q4
$1.39M Buy
18,095
+420
+2% +$31.6K 0.32% 80
2015
Q3
$1.18M Buy
17,675
+500
+3% +$36.8K 0.29% 89
2015
Q2
$1.27M Buy
17,175
+1,330
+8% +$102K 0.3% 88
2015
Q1
$1.24M Buy
15,845
+5,418
+52% +$411K 0.3% 89
2014
Q4
$753K Buy
10,427
+2,910
+39% +$202K 0.18% 136
2014
Q3
$466K Sell
7,517
-190
-2% -$12.1K 0.11% 204
2014
Q2
$491K Buy
7,707
+300
+4% +$18.2K 0.1% 200
2014
Q1
$456K Sell
7,407
-800
-10% -$46.6K 0.1% 207
2013
Q4
$471K Buy
8,207
+65
+0.8% +$3.69K 0.1% 190
2013
Q3
$434K Buy
8,142
+3,230
+66% +$174K 0.1% 199
2013
Q2
$254K Buy
+4,912
New +$243K 0.06% 289

Other funds holding MDT

Meiji Yasuda Asset Management's MDT Position: Q2 2026 in Review

Meiji Yasuda Asset Management increased its Medtronic (MDT) stake by 20% in Q2 2026, buying an estimated $2.08M and bringing the position to 153,980 shares worth $12M. The position accounts for 0.54% of the portfolio, ranked #42.

Meiji Yasuda Asset Management first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.5M in Q3 2024. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Meiji Yasuda Asset Management held 153,980 shares of Medtronic worth $12M as of Q2 2026.
  • Meiji Yasuda Asset Management bought 25,754 Medtronic shares in Q2 2026, an estimated $2.08M.
  • Medtronic made up 0.54% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #42 holding.
  • Meiji Yasuda Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Meiji Yasuda Asset Management's Medtronic position peaked at $15.5M in Q3 2024.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.